Alere Analytics Fauzia Khan to present keynote address at ACO Summit Alere Analytics.

Khan will moderate a panel of industry leaders in the ACO marketplace who’ll discuss real case study examples of effectively applying predictive analytics for population health administration. The ACO Summit: Monitor: Analytics and Health IT for Population Wellness Management keynote and Using Predictive Analytics for Population Health Management panel dialogue Keynote and Moderator: Dr. Fauzia Khan, Chief Medical Officer and Co-Founder, Alere Analytics, formerly DiagnosisOne When: Friday, 14 June, 2013, 9:00 and 9:20 a.m.. Alere Analytics’ Fauzia Khan to present keynote address at ACO Summit Alere Analytics, an Alere subsidiary focusing on analytics and clinical decision support technology, today announced that Chief Medical Officer and Co-founder, Dr.Adamas Pharmaceuticals forges contract with U.S. Naval Wellness Research Center for evaluating triple combination antiviral drug Adamas Pharmaceuticals, Inc., a held company privately, announced today that it offers entered into a Cooperative Analysis and Development Agreement with america Naval Health Research Middle for preclinical research evaluating Adamas’ triple combination antiviral medication therapy for influenza A, including novel influenza A/H1N1. TCAD therapy includes Adamas’ investigational proprietary fixed-dose oral mixture drug, to become administered with a neuraminidase inhibitor adjunctively, including Tamiflu . Under the CRADA, the U.S. Naval Health Research Center will conduct comparative tests of Adamas’ TCAD therapy against different strains of the influenza A virus, including seasonal influenza , avian influenza and novel influenza A/H1N1.